Auxilium Pharmaceuticals (AUXL -8%) drops after terminating its collaboration agreement with...

|About: Auxilium Pharmaceuticals, Inc. (AUXL)|By:, SA News Editor

Auxilium Pharmaceuticals (AUXL -8%) drops after terminating its collaboration agreement with Pfizer (PFE -1%) to develop the drug Xiapex, a treatment for Dupuytren's disease, in the European Union and certain other European and Eurasian countries. The agreement will terminate no later than April 24, 2013, after which rights to commercialize Xiapex will revert to AUXL.